Monitoring Alendronate and Estradiol Therapy With Quantitative Ultrasound and Bone Mineral Density

By Ingle Bridget M.   Machado Adriana B. C.   Pereda C. A.   Eastell Richard  

Journal of Clinical Densitometry, Vol. 8, Iss. 3, 2005-09 ,pp. : 278-286

Humana Press, Inc

Access to resources Recommend Favorite

Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis

By Sebba Anthony I.   Bonnick Sydney Lou   Kagan Risa   Thompson Desmond E.   Skalky Carol S.   Chen Erluo   de Papp Anne E.    

Current Medical Research and Opinion, Vol. 20, Iss. 12, 2004-12 ,pp. : 2031-2041

Informa Healthcare

Access to resources Recommend Favorite

Can the WHO definition of osteoporosis be applied to multi-site axial transmission quantitative ultrasound?

By Knapp K.   Blake G.   Spector T.   Fogelman I.  

Osteoporosis International, Vol. 15, Iss. 5, 2004-05 ,pp. : 367-374

Springer Publishing Company

Access to resources Recommend Favorite

A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis

By Gold Deborah T.   Martin Bradley C.   Frytak Jennifer R.   Amonkar Mayur M.   Cosman Felicia  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 585-594

Informa Healthcare

Access to resources Recommend Favorite

Quantitative Ultrasound and Mortality: A Prospective Study

By Bauer D. C.   Bauer D. C.   Palermo L.   Black D.   Cauleyfor the Study of Osteoporotic Fractures Research Group: Universities of California (San Francisco)   Pittsburgh   Minnesota (Minneapolis)   Kaiser Center for Health Research   Portland J. A.  

Osteoporosis International, Vol. 13, Iss. 8, 2002-08 ,pp. : 606-612

Springer Publishing Company

Access to resources Recommend Favorite